BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22998209)

  • 1. Association between ABCB1 genotype and seizure outcome in Collies with epilepsy.
    Muñana KR; Nettifee-Osborne JA; Bergman RL; Mealey KL
    J Vet Intern Med; 2012; 26(6):1358-64. PubMed ID: 22998209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease progression and treatment response of idiopathic epilepsy in Australian Shepherd dogs.
    Weissl J; Hülsmeyer V; Brauer C; Tipold A; Koskinen LL; Kyöstilä K; Lohi H; Sauter-Louis C; Wolf M; Fischer A
    J Vet Intern Med; 2012; 26(1):116-25. PubMed ID: 22182230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in the ABCB1 gene in phenobarbital responsive and resistant idiopathic epileptic Border Collies.
    Alves L; Hülsmeyer V; Jaggy A; Fischer A; Leeb T; Drögemüller M
    J Vet Intern Med; 2011; 25(3):484-9. PubMed ID: 21488961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromide therapy in refractory canine idiopathic epilepsy.
    Podell M; Fenner WR
    J Vet Intern Med; 1993; 7(5):318-27. PubMed ID: 8263851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of phenobarbital with bromide as a first-choice antiepileptic drug for treatment of epilepsy in dogs.
    Boothe DM; Dewey C; Carpenter DM
    J Am Vet Med Assoc; 2012 May; 240(9):1073-83. PubMed ID: 22515627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenobarbital or potassium bromide as an add-on antiepileptic drug for the management of canine idiopathic epilepsy refractory to imepitoin.
    Royaux E; Van Ham L; Broeckx BJ; Van Soens I; Gielen I; Deforce D; Bhatti SF
    Vet J; 2017 Feb; 220():51-54. PubMed ID: 28190495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imepitoin withdrawal in dogs with idiopathic epilepsy well-controlled with imepitoin and phenobarbital and/or potassium bromide does not increase seizure frequency.
    Stee K; Martlé V; Broeckx BJG; Royaux E; Van Ham L; Bhatti SFM
    Vet J; 2017 Dec; 230():1-5. PubMed ID: 29208209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiepileptic drug therapy.
    Podell M
    Clin Tech Small Anim Pract; 1998 Aug; 13(3):185-92. PubMed ID: 9775509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic administration of phenobarbital, or bromide, on pharmacokinetics of levetiracetam in dogs with epilepsy.
    Muñana KR; Nettifee-Osborne JA; Papich MG
    J Vet Intern Med; 2015; 29(2):614-9. PubMed ID: 25711374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of a general association between ABCB1 genetic variants and response to antiepileptic drugs in epilepsy patients.
    Grover S; Bala K; Sharma S; Gourie-Devi M; Baghel R; Kaur H; Gupta M; Talwar P; Kukreti R
    Biochimie; 2010 Sep; 92(9):1207-12. PubMed ID: 20417680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic serum drug concentrations in epileptic dogs treated with potassium bromide alone or in combination with other anticonvulsants: 122 cases (1992-1996).
    Trepanier LA; Van Schoick A; Schwark WS; Carrillo J
    J Am Vet Med Assoc; 1998 Nov; 213(10):1449-53. PubMed ID: 9828942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic epilepsy in dogs: owners' perspectives on management with phenobarbitone and/or potassium bromide.
    Chang Y; Mellor DJ; Anderson TJ
    J Small Anim Pract; 2006 Oct; 47(10):574-81. PubMed ID: 17004949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency of a single nucleotide substitution (c.-6-180T>G) of the canine MDR1/ABCB1 gene associated with phenobarbital-resistant idiopathic epilepsy in Border Collie dogs.
    Mizukami K; Yabuki A; Chang HS; Uddin MM; Rahman MM; Kushida K; Kohyama M; Yamato O
    Dis Markers; 2013; 35(6):669-72. PubMed ID: 24302812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of epilepsy of unknown origin in the Rottweiler breed.
    Heske L; Körberg IB; Nødtvedt A; Jäderlund KH
    Acta Vet Scand; 2015 Nov; 57():75. PubMed ID: 26546467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving seizure control in dogs with refractory epilepsy using gabapentin as an adjunctive agent.
    Govendir M; Perkins M; Malik R
    Aust Vet J; 2005 Oct; 83(10):602-8. PubMed ID: 16255282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum total thyroxine, total triiodothyronine, free thyroxine, and thyrotropin concentrations in epileptic dogs treated with anticonvulsants.
    Kantrowitz LB; Peterson ME; Trepanier LA; Melián C; Nichols R
    J Am Vet Med Assoc; 1999 Jun; 214(12):1804-8. PubMed ID: 10382022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of bromide in therapy resistant epilepsy of dogs].
    Schwartz-Porsche D; Jürgens U
    Tierarztl Prax; 1991 Aug; 19(4):395-401. PubMed ID: 1948987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.
    Seo T; Ishitsu T; Ueda N; Nakada N; Yurube K; Ueda K; Nakagawa K
    Pharmacogenomics; 2006 Jun; 7(4):551-61. PubMed ID: 16753003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Veterinarians' preferences for anticonvulsant drugs for treating seizure disorders in dogs and cats.
    Kluger EK; Malik R; Govendir M
    Aust Vet J; 2009 Nov; 87(11):445-9. PubMed ID: 19857237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and tolerability of levetiracetam in pharmacoresistant epileptic dogs.
    Volk HA; Matiasek LA; Luján Feliu-Pascual A; Platt SR; Chandler KE
    Vet J; 2008 Jun; 176(3):310-9. PubMed ID: 17468024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.